This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Lacticaseibacillus rhamnosus
- DrugBank Accession Number
- DB19282
- Background
Not Available
- Type
- Biotech
- Groups
- Approved, Investigational
- Synonyms
- Lacticaseibacillus rhamnosus
- Lactobacillus casei rhamnosus whole
- Lactobacillus casei subsp. rhamnosus whole
- Lactobacillus rhamnosus
- Lactobacillus rhamnosus (hansen, 1968) collins et al., 1989
- Lactobacillus rhamnosus whole
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Jangdaewon Nature kids Powder 26 mg/2g Oral Daewon Pharmaceutical Co., Ltd. 2019-02-01 Not applicable US 
Jangdaewon Nature Plus Powder 22.5 mg/3g Oral Daewon Pharmaceutical Co., Ltd. 2019-02-01 Not applicable US Jangdaewon Probiotics Powder 30 mg/2g Oral Daewon Pharmaceutical Co., Ltd. 2019-02-01 Not applicable US - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Fermalac Ecc 1b Lacticaseibacillus rhamnosus (0.7 b) + Lactobacillus delbrueckii bulgaricus (0.15 b) + Streptococcus thermophilus (0.15 b) Capsule, delayed release Oral Institut Rosell Inc. 1960-12-31 2009-09-08 Canada 
Intestalife Lacticaseibacillus rhamnosus (3.4 b) + Bifidobacterium longum (0.2 b) + Lactobacillus acidophilus (0.4 b) Capsule Oral Holista Health (Canada) Inc. 1997-09-04 2006-08-24 Canada - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Jangdaewon Nature kids Lacticaseibacillus rhamnosus (26 mg/2g) Powder Oral Daewon Pharmaceutical Co., Ltd. 2019-02-01 Not applicable US Jangdaewon Nature Plus Lacticaseibacillus rhamnosus (22.5 mg/3g) Powder Oral Daewon Pharmaceutical Co., Ltd. 2019-02-01 Not applicable US Jangdaewon Probiotics Lacticaseibacillus rhamnosus (30 mg/2g) Powder Oral Daewon Pharmaceutical Co., Ltd. 2019-02-01 Not applicable US
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 9601IVB87J
- CAS number
- Not Available
References
- General References
- Not Available
- External Links
- 100278
- Wikipedia
- Lacticaseibacillus_rhamnosus
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data4 Completed Prevention Asthma, Allergic 1 somestatus stop reason just information to hide 4 Completed Treatment Bacterial Vaginosis (BV) 1 somestatus stop reason just information to hide 3 Terminated Prevention Bacterial Vaginosis (BV) / Chronic Lung Disease of Prematurity / Periventricular Leukomalacia / Premature Births / Sepsis 1 somestatus stop reason just information to hide 3 Unknown Status Prevention Decreased carbohydrate and glucose tolerance / Pregnancy 1 somestatus stop reason just information to hide 2 Completed Treatment Abdominal Pain / Anxiety 1 somestatus stop reason just information to hide
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Capsule, delayed release Oral Powder Oral 26 mg/2g Powder Oral 22.5 mg/3g Powder Oral 30 mg/2g Capsule, coated Oral 400 million CFU Capsule Oral - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at July 15, 2024 14:05 / Updated at July 16, 2024 15:22